Acer Medical Statistics

Total Valuation

Acer Medical has a market cap or net worth of TWD 1.50 billion. The enterprise value is 1.32 billion.

Market Cap	1.50B
Enterprise Value	1.32B

Important Dates

The last earnings date was Friday, April 24, 2026.

Earnings Date	Apr 24, 2026
Ex-Dividend Date	n/a

Share Statistics

Acer Medical has 15.23 million shares outstanding. The number of shares has increased by 0.14% in one year.

Current Share Class	15.23M
Shares Outstanding	15.23M
Shares Change (YoY)	+0.14%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	4.78%
Owned by Institutions (%)	0.54%
Float	3.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	24.97
PB Ratio	9.09
P/TBV Ratio	9.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-44.59
EV / Sales	22.04
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.74, with a Debt / Equity ratio of 0.02.

Current Ratio	4.74
Quick Ratio	4.66
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2,518.00

Financial Efficiency

Return on equity (ROE) is -16.51% and return on invested capital (ROIC) is -11.30%.

Return on Equity (ROE)	-16.51%
Return on Assets (ROA)	-9.43%
Return on Invested Capital (ROIC)	-11.30%
Return on Capital Employed (ROCE)	-19.85%
Weighted Average Cost of Capital (WACC)	8.35%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.28
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.57% in the last 52 weeks. The beta is 0.75, so Acer Medical's price volatility has been lower than the market average.

Beta (5Y)	0.75
52-Week Price Change	-17.57%
50-Day Moving Average	99.06
200-Day Moving Average	111.83
Relative Strength Index (RSI)	49.67
Average Volume (20 Days)	2,077

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Acer Medical had revenue of TWD 60.05 million and -29.69 million in losses. Loss per share was -1.95.

Revenue	60.05M
Gross Profit	37.50M
Operating Income	-32.73M
Pretax Income	-29.69M
Net Income	-29.69M
EBITDA	-31.50M
EBIT	-32.73M
Loss Per Share	-1.95

Full Income Statement

Balance Sheet

The company has 178.65 million in cash and 2.50 million in debt, with a net cash position of 176.15 million or 11.57 per share.

Cash & Cash Equivalents	178.65M
Total Debt	2.50M
Net Cash	176.15M
Net Cash Per Share	11.57
Equity (Book Value)	164.92M
Book Value Per Share	10.84
Working Capital	158.11M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-24.65M
Capital Expenditures	n/a
Depreciation & Amortization	1.24M
Net Borrowing	2.50M
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 62.45%, with operating and profit margins of -54.51% and -49.43%.

Gross Margin	62.45%
Operating Margin	-54.51%
Pretax Margin	-49.43%
Profit Margin	-49.43%
EBITDA Margin	-52.45%
EBIT Margin	-54.51%
FCF Margin	n/a

Dividends & Yields

Acer Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.14%
Shareholder Yield	-0.14%
Earnings Yield	-1.98%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3